Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Mark

Showing results (131-140 of 331) with videos related to

Pageof 34
Sort By:
American Heart Journal|February 24, 2023
Clinical and cost implications of deferred testing in low-risk patients with stable chest pain: a simulation using the PROMISE trialMichael G Nanna, Eric Yow, Sreekanth Vemulapalli, et al.
JAMA|August 19, 2010
Effect of an implantable gentamicin-collagen sponge on sternal wound infections following cardiac surgery: a randomized trialElliott Bennett-Guerrero, T Bruce Ferguson, Min Lin, et al.
JACC. Cardiovascular Imaging|June 19, 2017
The External Validity of Prediction Models for the Diagnosis of Obstructive Coronary Artery Disease in Patients With Stable Chest Pain: Insights From the PROMISE TrialTessa S S Genders, Adrian Coles, Udo Hoffmann, et al.
American Heart Journal|March 30, 2002
Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonistsWojciech Mazur, Grzegorz L Kaluza, Shelly Sapp, et al.
JAMA Cardiology|August 27, 2025
Survival After Initial Stress Testing vs Anatomic Testing in Suspected Coronary Artery Disease: Long-Term Follow-Up of the PROMISE Randomized Clinical TrialPamela S Douglas, Amanda Stebbins, Borek Foldyna, et al.
Circulation. Cardiovascular Quality and Outcomes|April 4, 2022
Presenting Symptoms in Patients Undergoing Coronary Artery Disease Evaluation: Association With Noninvasive Test Results and Clinical Outcomes in the PROMISE TrialAngela Lowenstern, Karen P Alexander, Neha J Pagidipati, et al.
Circulation. Cardiovascular Quality and Outcomes|February 18, 2010
Representation of women in randomized clinical trials of cardiovascular disease preventionChiara Melloni, Jeffrey S Berger, Tracy Y Wang, et al.
Heart Rhythm O2|March 4, 2022
Diagnosis-to-ablation time predicts recurrent atrial fibrillation and rehospitalization following catheter ablationDerek S Chew, Kelley A Jones, Zak Loring, et al.
Lancet (London, England)|February 21, 2004
International differences in evolution of early discharge after acute myocardial infarctionPadma Kaul, L Kristin Newby, Yuling Fu, et al.
JAMA Network Open|December 14, 2020
Cost-effectiveness Analysis of Anatomic vs Functional Index Testing in Patients With Low-Risk Stable Chest PainJúlia Karády, Thomas Mayrhofer, Alexander Ivanov, et al.
Pageof 34

Showing results (131-140 of 331) with videos related to

Sort By:
Pageof 34
American Heart Journal|February 24, 2023
Clinical and cost implications of deferred testing in low-risk patients with stable chest pain: a simulation using the PROMISE trialMichael G Nanna, Eric Yow, Sreekanth Vemulapalli, et al.
JAMA|August 19, 2010
Effect of an implantable gentamicin-collagen sponge on sternal wound infections following cardiac surgery: a randomized trialElliott Bennett-Guerrero, T Bruce Ferguson, Min Lin, et al.
JACC. Cardiovascular Imaging|June 19, 2017
The External Validity of Prediction Models for the Diagnosis of Obstructive Coronary Artery Disease in Patients With Stable Chest Pain: Insights From the PROMISE TrialTessa S S Genders, Adrian Coles, Udo Hoffmann, et al.
American Heart Journal|March 30, 2002
Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonistsWojciech Mazur, Grzegorz L Kaluza, Shelly Sapp, et al.
JAMA Cardiology|August 27, 2025
Survival After Initial Stress Testing vs Anatomic Testing in Suspected Coronary Artery Disease: Long-Term Follow-Up of the PROMISE Randomized Clinical TrialPamela S Douglas, Amanda Stebbins, Borek Foldyna, et al.
Circulation. Cardiovascular Quality and Outcomes|April 4, 2022
Presenting Symptoms in Patients Undergoing Coronary Artery Disease Evaluation: Association With Noninvasive Test Results and Clinical Outcomes in the PROMISE TrialAngela Lowenstern, Karen P Alexander, Neha J Pagidipati, et al.
Circulation. Cardiovascular Quality and Outcomes|February 18, 2010
Representation of women in randomized clinical trials of cardiovascular disease preventionChiara Melloni, Jeffrey S Berger, Tracy Y Wang, et al.
Heart Rhythm O2|March 4, 2022
Diagnosis-to-ablation time predicts recurrent atrial fibrillation and rehospitalization following catheter ablationDerek S Chew, Kelley A Jones, Zak Loring, et al.
Lancet (London, England)|February 21, 2004
International differences in evolution of early discharge after acute myocardial infarctionPadma Kaul, L Kristin Newby, Yuling Fu, et al.
JAMA Network Open|December 14, 2020
Cost-effectiveness Analysis of Anatomic vs Functional Index Testing in Patients With Low-Risk Stable Chest PainJúlia Karády, Thomas Mayrhofer, Alexander Ivanov, et al.
Pageof 34